The state of Oklahoma currently has 2 active clinical trials seeking participants for Dementia research studies. These trials are conducted in various cities, including Oklahoma City, Tulsa, Norman and Edmond.
Alzheimer's Disease Neuroimaging Initiative 4
NCT05617014
Recruiting
Since its launch in 2004, the overarching aim of the Alzheimer's Disease Neuroimaging Initiative (ADNI) Study has been to validate biomarkers for Alzheimer's disease (AD) clinical trials. ADNI4 continues the previously funded ADNI1, ADNI-GO, ADNI2, and ADNI3 studies that have combined public/private collaborations between academia and industry to determine the relationships between the clinical, cognitive, imaging, genetic and biochemical biomarker characteristics of the entire spectrum of AD.
Gender:
ALL
Ages:
Between 55 years and 90 years
Trial Updated:
04/09/2025
Locations: Central States Research, Tulsa, Oklahoma
Conditions: Mild Cognitive Impairment, Alzheimer Disease, Dementia
Register for Updates
Urolithin A Supplementation in Middle-aged Adults With Obesity
NCT05921266
Recruiting
The goal of this clinical trial is to learn about the effect of urolithin A, a dietary supplement, on blood flow in middle-aged adults with obesity. The main question it aims to answer is: - Does urolithin A supplementation improve blood flow in large and small blood vessels in middle-aged adults with obesity? Participants will be asked to: * Take the dietary supplement daily for 4 weeks * Attend two study visits to have their blood vessels checked, answer questionnaires, and give a sample of... Read More
Gender:
ALL
Ages:
Between 40 years and 64 years
Trial Updated:
01/22/2025
Locations: Translational GeroScience Laboratory - O'Donoghue Research Building, Oklahoma City, Oklahoma
Conditions: Obesity, Vascular Dementia, Cognitive Impairment
Register for Updates